
Dameron Levest Jones
Examiner (ID: 18762, Phone: (571)272-0617 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1621, 1616, 3991, 1211, 1618, RD00, 1619, 1622, 1615 |
| Total Applications | 2574 |
| Issued Applications | 1523 |
| Pending Applications | 392 |
| Abandoned Applications | 685 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8516930
[patent_doc_number] => 20120316338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-13
[patent_title] => 'Methods and Intermediates for the Preparation of Optionally Radio-Labeled Imatinib'
[patent_app_type] => utility
[patent_app_number] => 13/526115
[patent_app_country] => US
[patent_app_date] => 2012-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7537
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13526115
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/526115 | Methods and Intermediates for the Preparation of Optionally Radio-Labeled Imatinib | Jun 17, 2012 | Abandoned |
Array
(
[id] => 8527368
[patent_doc_number] => 08303936
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-06
[patent_title] => 'Optical fluorescent imaging'
[patent_app_type] => utility
[patent_app_number] => 13/525136
[patent_app_country] => US
[patent_app_date] => 2012-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17278
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13525136
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/525136 | Optical fluorescent imaging | Jun 14, 2012 | Issued |
Array
(
[id] => 8853056
[patent_doc_number] => 20130142732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'RECOMBINANT FLUORESCENT NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 13/487921
[patent_app_country] => US
[patent_app_date] => 2012-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6899
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13487921
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/487921 | RECOMBINANT FLUORESCENT NANOPARTICLES | Jun 3, 2012 | Abandoned |
Array
(
[id] => 11224509
[patent_doc_number] => 09452219
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-27
[patent_title] => 'Anti-nucleolin agent-conjugated nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 14/122617
[patent_app_country] => US
[patent_app_date] => 2012-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 32
[patent_no_of_words] => 7540
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122617
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/122617 | Anti-nucleolin agent-conjugated nanoparticles | May 31, 2012 | Issued |
Array
(
[id] => 8565943
[patent_doc_number] => 20120328515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-27
[patent_title] => 'IN VIVO DETECTION OF APOPTOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/480072
[patent_app_country] => US
[patent_app_date] => 2012-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9345
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13480072
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/480072 | IN VIVO DETECTION OF APOPTOSIS | May 23, 2012 | Abandoned |
Array
(
[id] => 8482771
[patent_doc_number] => 20120282178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules'
[patent_app_type] => utility
[patent_app_number] => 13/474260
[patent_app_country] => US
[patent_app_date] => 2012-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 45774
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13474260
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/474260 | Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules | May 16, 2012 | Issued |
Array
(
[id] => 8522155
[patent_doc_number] => 20120321563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'Carbonic Anhydrase Targeting Agents and Methods of Using Same'
[patent_app_type] => utility
[patent_app_number] => 13/467694
[patent_app_country] => US
[patent_app_date] => 2012-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 28585
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13467694
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/467694 | Carbonic anhydrase targeting agents and methods of using same | May 8, 2012 | Issued |
Array
(
[id] => 9517692
[patent_doc_number] => 20140154184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'TIME-GATED FLUORESCENCE IMAGING WITH SI-CONTAINING PARTICLES'
[patent_app_type] => utility
[patent_app_number] => 14/113960
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6818
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113960
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/113960 | TIME-GATED FLUORESCENCE IMAGING WITH SI-CONTAINING PARTICLES | Apr 26, 2012 | Abandoned |
Array
(
[id] => 11229894
[patent_doc_number] => 09457106
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-04
[patent_title] => 'Cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 14/112797
[patent_app_country] => US
[patent_app_date] => 2012-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 6067
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112797
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112797 | Cancer therapy | Apr 17, 2012 | Issued |
Array
(
[id] => 10147949
[patent_doc_number] => 09180214
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-11-10
[patent_title] => 'Gonadotropin-releasing hormone receptor-targeting peptides and their use to treat and diagnose cancer'
[patent_app_type] => utility
[patent_app_number] => 13/447918
[patent_app_country] => US
[patent_app_date] => 2012-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 23810
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13447918
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/447918 | Gonadotropin-releasing hormone receptor-targeting peptides and their use to treat and diagnose cancer | Apr 15, 2012 | Issued |
Array
(
[id] => 8489038
[patent_doc_number] => 20120288445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'RADIOLABELLING'
[patent_app_type] => utility
[patent_app_number] => 13/447030
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5956
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13447030
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/447030 | RADIOLABELLING | Apr 12, 2012 | Abandoned |
Array
(
[id] => 10925741
[patent_doc_number] => 20140328762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-06
[patent_title] => 'Fluorogenic Peptide Probes and Assays'
[patent_app_type] => utility
[patent_app_number] => 14/110002
[patent_app_country] => US
[patent_app_date] => 2012-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 9992
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110002
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/110002 | Fluorogenic Peptide Probes and Assays | Apr 5, 2012 | Abandoned |
Array
(
[id] => 9574686
[patent_doc_number] => 08765096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-01
[patent_title] => 'Methods and compositions for treating and diagnosing kidney disease'
[patent_app_type] => utility
[patent_app_number] => 13/440641
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 15632
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13440641
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/440641 | Methods and compositions for treating and diagnosing kidney disease | Apr 4, 2012 | Issued |
Array
(
[id] => 11388766
[patent_doc_number] => 09549997
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-24
[patent_title] => 'Optical imaging probes'
[patent_app_type] => utility
[patent_app_number] => 14/110616
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 13405
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110616
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/110616 | Optical imaging probes | Apr 4, 2012 | Issued |
Array
(
[id] => 8431285
[patent_doc_number] => 20120253160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'Methods and Reagents for in Vivo Imaging of Cancel Cell Lines'
[patent_app_type] => utility
[patent_app_number] => 13/439279
[patent_app_country] => US
[patent_app_date] => 2012-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8960
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13439279
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/439279 | Methods and Reagents for in Vivo Imaging of Cancel Cell Lines | Apr 3, 2012 | Abandoned |
Array
(
[id] => 13011845
[patent_doc_number] => 10029023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Theranostic imaging agents and methods of use
[patent_app_type] => utility
[patent_app_number] => 14/008715
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 11968
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008715
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/008715 | Theranostic imaging agents and methods of use | Mar 29, 2012 | Issued |
Array
(
[id] => 10000446
[patent_doc_number] => 09044520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-02
[patent_title] => 'Compound accumulating in inflammatory site, diagnostic agent containing the compound in labeled state and its precursor compound for labeling'
[patent_app_type] => utility
[patent_app_number] => 13/434722
[patent_app_country] => US
[patent_app_date] => 2012-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 8489
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13434722
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/434722 | Compound accumulating in inflammatory site, diagnostic agent containing the compound in labeled state and its precursor compound for labeling | Mar 28, 2012 | Issued |
Array
(
[id] => 9204864
[patent_doc_number] => 20140004041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'TECHNETIUM LABELLED PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/002021
[patent_app_country] => US
[patent_app_date] => 2012-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11179
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002021
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/002021 | Technetium labelled peptides | Mar 1, 2012 | Issued |
Array
(
[id] => 8577251
[patent_doc_number] => 08343460
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-01
[patent_title] => 'Methods and compositions for F-18 labeling of proteins, peptides and molecules'
[patent_app_type] => utility
[patent_app_number] => 13/408580
[patent_app_country] => US
[patent_app_date] => 2012-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 22
[patent_no_of_words] => 23080
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13408580
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/408580 | Methods and compositions for F-18 labeling of proteins, peptides and molecules | Feb 28, 2012 | Issued |
Array
(
[id] => 10514985
[patent_doc_number] => 09242016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-26
[patent_title] => 'Gold coated lanthanide nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 13/342823
[patent_app_country] => US
[patent_app_date] => 2012-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11236
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13342823
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/342823 | Gold coated lanthanide nanoparticles | Jan 2, 2012 | Issued |